Ng, R. A., Barratt, S., Parisian, A., Palanisamy, G. S., Phukan, S., Sun, R., . . . Myles, D. C. Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD). American Chemical Society.
Chicago Style (17th ed.) CitationNg, Raymond A., et al. Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD). American Chemical Society.
MLA (9th ed.) CitationNg, Raymond A., et al. Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD). American Chemical Society.
Warning: These citations may not always be 100% accurate.